Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CureVac N.V. - Ordinary Shares (NQ:CVAC)

4.660 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CureVac N.V. - Ordinary Shares

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Moderna and Pfizer May Benefit From This Rival's Bad News ↗
And it could equal billions of dollars for these vaccine leaders. 
Via The Motley Fool
Topics Cannabis
News headline image
Can CureVac Recover After Its Vaccine Setback? ↗
Investors' dreams of a third strong mRNA vaccine may be over. 
Via The Motley Fool
Topics Cannabis
News headline image
30 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 104.6% to $62.00. Pop Culture Group shares jumped 405% on Wednesday after the company priced its IPO at $6 per... 
Via Benzinga
Topics Initial Public Offering
Why CureVac Shares Are Trading Lower Today ↗
CureVac BV (NASDAQ:CVAC) shares are trading lower by 3.6% ... 
Via Benzinga
CVAC Stock Price Increases 14%: Why It Happened ↗
CureVac BV (NASDAQ:CVAC) shares are trading higher by 14% ... 
Via Benzinga
News headline image
58 Biggest Movers From Yesterday ↗
Gainers The Glimpse Group, Inc. (NASDAQ: VRAR) shares jumped 152.3% to settle at $17.66 on Thursday after the company priced its IPO at $7 per share. Pop Culture Group Co., Ltd (... 
Via Benzinga
Topics Initial Public Offering
News headline image
Analyzing CureVac's Unusual Options Activity ↗
CureVac (NASDAQ:CVAC) shares experienced unusual options activity on Thursday. The stock price moved down to $68.53 following the option alert. Sentiment: BULLISH Option Type:... 
Via Benzinga
News headline image
20 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers Alterity Therapeutics Ltd (NASDAQ: ATHE) shares rose 64% to $2.14 in pre-market trading. Alterity Therapeutics recently said it received EU regulatory guidance for ATH434... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE... 
Via Benzinga
News headline image
A Peek Into The Markets: US Stock Futures Up Ahead Of Initial Jobless Claims Data ↗
Pre-open movers U.S. stock futures traded higher in early pre-market trade ahead of initial jobless claims data. The Dow Jones climbed over 200 points on Wednesday, while the S... 
Via Benzinga
Topics Stocks
News headline image
CureVac Stock Drops After Final Results Confirm Its COVID-19 Vaccine Trails Rivals ↗
The German biotech company CureVac BV (NASDAQ: CVAC) announced on Wednesday after hours the final results of its late-stage COVID-19 vaccine trial showing 48%... 
Via Benzinga
News headline image
CureVac Final Data from Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV, Demonstrates Protection in Age Group of 18 to 60
- Unique pivotal study conducted in 10 countries in fast changing variant environment; 15 COVID-19 variant strains present for efficacy analysis; original strain almost completely absent - Statistical... 
From CureVac
Via AccessWire
Topics Intellectual Property Regulatory Compliance
News headline image
CureVac Announces Appointment of Dr. Malte Greune as Chief Operating Officer and Transition of Dr. Florian von der Mülbe to Lead Accelerated Development of The RNA Printer(R)
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / June 30, 2021 / CureVac N.V. (NASDAQ:CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on... 
From CureVac
Via AccessWire
Topics Intellectual Property Regulatory Compliance
News headline image
June’s Best and Worst Performing Russell 1,000 Stocks ↗
The month of June, the second quarter and the first half of 2021 are almost in the bag. 
Via Talk Markets
News headline image
Without a Coronavirus Vaccine Of Its Own, Is There Any Hope For CureVac Stock? ↗
Things are looking bleak right now, but they might improve with enough time. 
Via The Motley Fool
News headline image
CureVac Announces Voting Results of General Meeting
TÜBINGEN, GERMANY andBOSTON, MA / ACCESSWIRE / June 25, 2021 / CureVac N.V. (NASDAQ:CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on... 
From CureVac
Via AccessWire
Topics Intellectual Property Regulatory Compliance
News headline image
CureVac Provides Supervisory Board Update
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / June 23, 2021 / CureVac N.V. (NASDAQ:CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on... 
From CureVac
Via AccessWire
Topics Intellectual Property Regulatory Compliance
News headline image
Could CureVac Be a Millionaire-Maker Stock? ↗
CureVac's first COVID vaccine candidate disappointed investors. But a second one looks promising. 
Via The Motley Fool
News headline image
How Pfizer and Moderna Could Profit Big-Time From AstraZeneca's and CureVac's Challenges ↗
Bad news for AstraZeneca and CureVac should mean more good news for Pfizer and Moderna. 
Via The Motley Fool
News headline image
Europe Purchases Additional 150M Doses Of Moderna COVID-19 Vaccine ↗
The European Union has decided to take up an option under a supply contract with Moderna Inc (NASDAQ: MRNA) that allows the bloc to order 150 million... 
Via Benzinga
News headline image
Why Is Everyone Talking About CureVac Stock? ↗
This coronavirus vaccine developer just hit a massive stumbling block. 
Via The Motley Fool
News headline image
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs ↗
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries. The U.S. Federal... 
Via Benzinga
News headline image
58 Biggest Movers From Friday ↗
Gainers CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.... 
Via Benzinga
News headline image
Stock Market Rally Shifts To Tech After Fed Meeting; Adobe, Ford In Focus: Weekly Review ↗
Techs seized stock market leadership, despite the Fed signaling earlier rate hikes. But many real economy names dived. 
Via Investor's Business Daily
Topics Economy Stocks
News headline image
32 Stocks Moving In Friday's Mid-Day Session ↗
Gainers CAI International, Inc. (NYSE: CAI) shares jumped 46.4% to $55.86 after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Sykes Enterprises,... 
Via Benzinga
News headline image
28 Stocks Moving in Friday's Pre-Market Session ↗
Gainers CAI International, Inc. (NYSE: CAI) rose 45.1% to $55.35 in pre-market trading after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Geron... 
Via Benzinga
News headline image
12 Words From CureVac's CEO That Could Mean Billions for Moderna and Pfizer ↗
The news may reinforce Moderna's and Pfizer's vaccine-market dominance. 
Via The Motley Fool
Topics Supply Chain
News headline image
50 Biggest Movers From Yesterday ↗
Gainers Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO at $19 per share. Midatech Pharma plc (NASDAQ... 
Via Benzinga
Topics Initial Public Offering
News headline image
Tesla Partner CureVac Says Will Find 'Sweet Spot' For COVID-19 Vaccine Despite Disappointing Data ↗
CureVac N.V.’s (NASDAQ: CVAC) Chief Financial Officer Pierre Kemula is optimistic its COVID-19 vaccine could still be offered to certain age groups or as a booster, the... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Nasdaq Gains Over 100 Points; CureVac Shares Plummet ↗
Toward the end of trading Thursday, the Dow traded down 0.67% to 33,806.27 while the NASDAQ rose 0.91% to 14,167.03. The S&P also fell, dropping 0.02% to 4,222.94. The U.S.... 
Via Benzinga
Topics Stocks
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.